Table 2.
Plasma High-Sensitivity Cardiac Troponin I Concentration in the Per-Protocol Population
| Overall (N = 191) | Ticagrelor (n = 94) | Placebo (n = 97) | p Value∗ | |
|---|---|---|---|---|
| Coronary 18F-fluoride uptake, ng/l | ||||
| N | 120 | 59 | 61 | |
| Baseline | 3.8 ± 2.9 | 4.2 ± 2.9 | 3.5 ± 3.0 | 0.197 |
| 30 days | 3.6 ± 2.7 | 4.1 ± 2.5 | 3.2 ± 2.9 | 0.072 |
| Ratio of 30 days to baseline | 0.95 ± 1.87 | 0.97 ± 2.13 | 0.93 ± 1.59 | 0.907 |
| No coronary 18F-fluoride uptake, ng/l | ||||
| N | 71 | 35 | 36 | |
| Baseline | 2.5 ± 2.6 | 2.5 ± 2.8 | 2.4 ± 2.4 | 0.872 |
| 30 days | 2.4 ± 2.7 | 2.4 ± 2.8 | 2.3 ± 2.6 | 0.877 |
| Ratio of 30 days to baseline | 0.97 ± 1.68 | 0.97 ± 1.77 | 0.96 ± 1.59 | |
Values are geometric mean ± geometric SD, back-transformed from log-transformed values, unless otherwise indicated.
∗
Post-hoc analysis.